Omnicell Inc

OMCL · Moat type: UNBESTIMMT

MoatScore

2/10

Fair Value

39 USD

Margin of Safety

-21.0 %

Rating

MEIDEN

Omnicell develops and markets automated medication management systems and related software and service solutions for hospitals and pharmacies, and generates revenue from the sale of hardware dispensing units as well as from recurring software subscriptions and service contracts.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.